Literature DB >> 12653839

Evaluation of CD4+ T cells proliferating to grass pollen in seasonal allergic subjects by flow cytometry.

A C Rimaniol1, G Garcia, S J Till, F Capel, G Gras, K Balabanian, D Emilie, M Humbert.   

Abstract

Our objective was to characterize T-cell responses to Phleum pratense in grass pollen allergic individuals and healthy controls using the fluorescent dye PKH26. Peripheral blood mononuclear cells were stimulated with P. pratense, or with recall antigens, and CD3+/CD4+ and CD3+/CD8+ T-cells that had proliferated were analysed by flow cytometry. In the presence of P. pratense CD4+/CD3+ T-cells proliferated more in grass pollen sensitive atopic patients than in nonallergic controls or in nongrass pollen sensitive atopic subjects. PPD and TT recall antigens elicited uniformly high proliferation in all T-cell subsets. Only half of pollen sensitive patients also had an increased proliferation of CD3+/CD8+ T-cells in response to P. pratense. We determined precursor frequency of CD4+ T cells in the original population that responded to P. pratense and found values ranging from 1 x 10-3 to 0.6 x 10-1, in the same range as those measured for PPD and TT. In conclusion, grass pollen sensitive atopic patients show enhanced CD4+ T-cell reactivity to P. pratense, and this could be related to the presence of elevated numbers of circulating allergen-specific CD4+ T cells. This flow cytometric method should allow the identification of other phenotypic markers such as intracellular cytokines in allergen specific responding CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653839      PMCID: PMC1808661          DOI: 10.1046/j.1365-2249.2003.02118.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens.

Authors:  A L Givan; J L Fisher; M Waugh; M S Ernstoff; P K Wallace
Journal:  J Immunol Methods       Date:  1999-11-19       Impact factor: 2.303

2.  Peripheral blood CD4+ and CD8+ T cell type 1 and type 2 cytokine production in atopic asthmatic and normal subjects.

Authors:  S-H Cho; L A Stanciu; T Begishivili; P J Bates; S T Holgate; S L Johnston
Journal:  Clin Exp Allergy       Date:  2002-03       Impact factor: 5.018

3.  IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression.

Authors:  S Till; S Durham; R Dickason; D Huston; J Bungre; S Walker; D Robinson; A B Kay; C Corrigan
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

4.  Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid.

Authors:  S R Durham; H J Gould; C P Thienes; M R Jacobson; K Masuyama; S Rak; O Lowhagen; E Schotman; L Cameron; Q A Hamid
Journal:  Eur J Immunol       Date:  1997-11       Impact factor: 5.532

5.  Human atopen-specific types 1 and 2 T helper cell clones.

Authors:  E A Wierenga; M Snoek; H M Jansen; J D Bos; R A van Lier; M L Kapsenberg
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

6.  T-cell and antibody response to Parietaria judaica allergenic fractions in atopic and nonatopic individuals.

Authors:  F Sallusto; F Quintieri; O Pugliese; G Reale; C Pini; G Di Felice
Journal:  Allergy       Date:  1993-01       Impact factor: 13.146

7.  Frequency of allergen-specific T lymphocytes in blood and bronchial response to allergen in asthma.

Authors:  S E Burastero; D Fenoglio; E Crimi; V Brusasco; G A Rossi
Journal:  J Allergy Clin Immunol       Date:  1993-05       Impact factor: 10.793

8.  Dissection of the grass allergen-specific immune response in patients with allergies and control subjects: T-cell proliferation in patients does not correlate with specific serum IgE and skin reactivity.

Authors:  P A Würtzen; R J van Neerven; J Arnved; H Ipsen; S H Sparholt
Journal:  J Allergy Clin Immunol       Date:  1998-02       Impact factor: 10.793

9.  IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease.

Authors:  S Till; R Dickason; D Huston; M Humbert; D Robinson; M Larché; S Durham; A B Kay; C Corrigan
Journal:  J Allergy Clin Immunol       Date:  1997-04       Impact factor: 10.793

10.  Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls.

Authors:  M Imada; F E Simons; F T Jay; K T Hayglass
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

  10 in total
  6 in total

Review 1.  Flow cytometric analysis of circulating microparticles in plasma.

Authors:  Aaron F Orozco; Dorothy E Lewis
Journal:  Cytometry A       Date:  2010-06       Impact factor: 4.355

2.  Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.

Authors:  Anu K Immonen; Antti H Taivainen; Ale T O Närvänen; Tuure T Kinnunen; Soili A Saarelainen; Marja A Rytkönen-Nissinen; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

3.  Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.

Authors:  David L Stachura; Stella T Chou; Mitchell J Weiss
Journal:  Blood       Date:  2005-09-06       Impact factor: 22.113

4.  Allergen-specific T cell quantity in blood is higher in allergic compared to nonallergic individuals.

Authors:  Aito Ueno-Yamanouchi; Faisal M Khan; Bazir Serushago; Tom Bowen; Cathy Lu; Joanne Luider; Jan Storek
Journal:  Allergy Asthma Clin Immunol       Date:  2011-04-17       Impact factor: 3.406

5.  Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.

Authors:  Haïfa Hamdi; Xavier Mariette; Véronique Godot; Karin Weldingh; Abdul Monem Hamid; Maria-Victoria Prejean; Gabriel Baron; Marc Lemann; Xavier Puechal; Maxime Breban; Francis Berenbaum; Jean-Charles Delchier; René-Marc Flipo; Bertrand Dautzenberg; Dominique Salmon; Marc Humbert; Dominique Emilie
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

6.  Th17 responses are not altered by natural exposure to seasonal allergens in pollen-sensitive patients.

Authors:  Agata Schramm; Barbara Jasiewicz-Honkisz; Grzegorz Osmenda; Grzegorz Wilk; Mateusz Siedlinski; Agnieszka Sagan; Pawel T Matusik; Joanna Maciag; Tomasz Sliwa; Marta Czesnikiewicz-Guzik; Tomasz P Mikolajczyk
Journal:  Allergy Asthma Clin Immunol       Date:  2016-10-24       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.